GE Healthcare is an innovator of global cutting-edge medical technology, diagnostic drugs and digital solutions. It is committed to making hospital operations more efficient, clinical diagnosis more effective, treatments more accurate, and patients healthier by providing integrated solutions, services, and data analysis. and happiness. In the more than 100 years of serving patients and medical institutions, GE Medical has continued to promote personalized, interconnected and more empathetic medical care, while simplifying the patient diagnosis and treatment process. GE Medical's medical imaging, ultrasound, life care and diagnostic drug business covers medical care in all aspects from diagnosis, treatment to monitoring. GE Medical was listed on the Nasdaq Stock Exchange in January 2023. The company's business covers more than 160 countries and regions. Since starting to serve Chinese patients in 1897, GE Medical has begun a century-long process of development in China. GE Medical established its China office in Beijing in 1986. In 1991, it jointly built a local factory "GE Hangwei" (Hangwei General Electric Medical Systems Co., Ltd.) with the former Ministry of Aerospace and the Ministry of Health. So far, it has been all over the country. It has more than 30 offices and has built three "creation centers" in Beijing, Wuxi and Shanghai. It has more than 7,000 employees and a local R&D team of about 1,800 people. Since 2011, it has led the research and development and marketed nearly 110 innovative products. In China, GE Medical has improved the accessibility of precision medicine and high-quality medical resources, and helped the construction of "Healthy China 2030". As one of the first multinational companies to start domestic layout, GE Medical has five major production bases (including six factories) in Beijing, Shanghai, Wuxi, Tianjin and Chengdu, and has built a "domestic" full coverage from universal and affordable to high-end. ability. GE Medical produces CT, X-ray machines, vascular machines, surgical machines and other imaging equipment in Beijing; builds a contrast agent production base in Shanghai; produces magnetic resonance imaging systems in Tianjin; produces ultrasound, anesthesia, electrocardiogram monitoring, and ventilators in Wuxi. , patient monitoring and other clinical nursing equipment. GE Medical's fifth production base in China is under construction in Chengdu; the production base of Sinopharm Devices and GE Medical Joint Venture is under construction in Shenzhen.
General Electric Company
GE Healthcare is an innovator of global cutting-edge medical technology, diagnostic drugs and digital solutions. It is committed to making hospital operations more efficient, clinical diagnosis more effective, treatments more accurate, and patients healthier by providing integrated solutions, services, and data analysis. and happiness. In the more than 100 years of serving patients and medical institutions, GE Medical has continued to promote personalized, interconnected and more empathetic medical care, while simplifying the patient diagnosis and treatment process. GE Medical's medical imaging, ultrasound, life care and diagnostic drug business covers medical care in all aspects from diagnosis, treatment to monitoring. GE Medical was listed on the Nasdaq Stock Exchange in January 2023. The company's business covers more than 160 countries and regions. Since starting to serve Chinese patients in 1897, GE Medical has begun a century-long process of development in China. GE Medical established its China office in Beijing in 1986. In 1991, it jointly built a local factory "GE Hangwei" (Hangwei General Electric Medical Systems Co., Ltd.) with the former Ministry of Aerospace and the Ministry of Health. So far, it has been all over the country. It has more than 30 offices and has built three "creation centers" in Beijing, Wuxi and Shanghai. It has more than 7,000 employees and a local R&D team of about 1,800 people. Since 2011, it has led the research and development and marketed nearly 110 innovative products. In China, GE Medical has improved the accessibility of precision medicine and high-quality medical resources, and helped the construction of "Healthy China 2030". As one of the first multinational companies to start domestic layout, GE Medical has five major production bases (including six factories) in Beijing, Shanghai, Wuxi, Tianjin and Chengdu, and has built a "domestic" full coverage from universal and affordable to high-end. ability. GE Medical produces CT, X-ray machines, vascular machines, surgical machines and other imaging equipment in Beijing; builds a contrast agent production base in Shanghai; produces magnetic resonance imaging systems in Tianjin; produces ultrasound, anesthesia, electrocardiogram monitoring, and ventilators in Wuxi. , patient monitoring and other clinical nursing equipment. GE Medical's fifth production base in China is under construction in Chengdu; the production base of Sinopharm Devices and GE Medical Joint Venture is under construction in Shenzhen.
United Imaging Healthcare Co., Ltd.
Shanghai Lianying Medical Technology Co., Ltd. is committed to providing global customers with all independently developed high-performance medical imaging diagnostic and therapeutic equipment, life science instruments, and innovative solutions covering the entire chain of "basic research-clinical research-medical transformation". Through in-depth collaboration with global universities, hospitals, research institutions and industrial partners, we will continue to break through the boundaries of scientific and technological innovation, accelerate the promotion of precise diagnosis and treatment and forward-looking scientific research exploration, and continuously improve the accessibility of global high-end medical equipment and services.
United Imaging Healthcare Co., Ltd.
Shanghai Lianying Medical Technology Co., Ltd. is committed to providing global customers with all independently developed high-performance medical imaging diagnostic and therapeutic equipment, life science instruments, and innovative solutions covering the entire chain of "basic research-clinical research-medical transformation". Through in-depth collaboration with global universities, hospitals, research institutions and industrial partners, we will continue to break through the boundaries of scientific and technological innovation, accelerate the promotion of precise diagnosis and treatment and forward-looking scientific research exploration, and continuously improve the accessibility of global high-end medical equipment and services.
Siemens Medical is a world-renowned medical technology company. For 130 years, it has led the innovation of medical technology. The company continues to develop innovative products and services, including artificial intelligence-based applications and digital products that play an increasingly important role in the development of the new generation of medical technology, and further consolidates the fields of in vitro diagnosis, image-guided treatment, in vivo diagnosis and new cancer diagnosis and treatment. The basis of At the same time, Siemens Medical provides a wide range of services and solutions to help medical service providers improve their capabilities and provide patients with high-quality and efficient services. In order to achieve the goal of "Siemens Medical 2025 Strategy", by accelerating business expansion, exploring growth markets related to core businesses such as artificial intelligence, future diagnosis and treatment or technical support services, and completing the next phase of the goal in a more targeted way and method. , further consolidate our market leadership position. In China, Siemens Medical is committed to becoming a trusted partner for China's medical and health system and Chinese patients by meeting the most pressing medical needs. The company has launched a new China strategy for the next three years, and will be "customer-centric" in all aspects, targeting the differentiated needs of different customer groups, establishing a more focused and professional team, and providing an overall solution driven by digitalization. , meet the needs of Chinese customers. In 2022, Siemens Medical China officially released the localization strategy of "National Intelligence Innovation", aiming to deeply participate in the construction of a healthy China as a Chinese company. The upgraded strategy is divided into three dimensions: First, the company will gradually promote the localization of the entire product line, further enrich and improve the product lineage, meet the diversified needs of Chinese customers and patients, and help the local industrial chain transform and upgrade. Second, based on the demand of the Chinese market, the company further deepens its innovation and research and development. On the one hand, it accelerates the implementation of global leading technologies in China, benefiting doctors and patients as soon as possible, and on the other hand, it continues to explore local innovation. Third, the company continues to promote the upgrading of local business models, improve the large-scale application of medical equipment in all fields of the disease process, gradually improve the industrial ecology, and explore and practice multi-dimensional medical and industrial collaborative innovation model.
Siemens Healthineers AG
Siemens Medical is a world-renowned medical technology company. For 130 years, it has led the innovation of medical technology. The company continues to develop innovative products and services, including artificial intelligence-based applications and digital products that play an increasingly important role in the development of the new generation of medical technology, and further consolidates the fields of in vitro diagnosis, image-guided treatment, in vivo diagnosis and new cancer diagnosis and treatment. The basis of At the same time, Siemens Medical provides a wide range of services and solutions to help medical service providers improve their capabilities and provide patients with high-quality and efficient services. In order to achieve the goal of "Siemens Medical 2025 Strategy", by accelerating business expansion, exploring growth markets related to core businesses such as artificial intelligence, future diagnosis and treatment or technical support services, and completing the next phase of the goal in a more targeted way and method. , further consolidate our market leadership position. In China, Siemens Medical is committed to becoming a trusted partner for China's medical and health system and Chinese patients by meeting the most pressing medical needs. The company has launched a new China strategy for the next three years, and will be "customer-centric" in all aspects, targeting the differentiated needs of different customer groups, establishing a more focused and professional team, and providing an overall solution driven by digitalization. , meet the needs of Chinese customers. In 2022, Siemens Medical China officially released the localization strategy of "National Intelligence Innovation", aiming to deeply participate in the construction of a healthy China as a Chinese company. The upgraded strategy is divided into three dimensions: First, the company will gradually promote the localization of the entire product line, further enrich and improve the product lineage, meet the diversified needs of Chinese customers and patients, and help the local industrial chain transform and upgrade. Second, based on the demand of the Chinese market, the company further deepens its innovation and research and development. On the one hand, it accelerates the implementation of global leading technologies in China, benefiting doctors and patients as soon as possible, and on the other hand, it continues to explore local innovation. Third, the company continues to promote the upgrading of local business models, improve the large-scale application of medical equipment in all fields of the disease process, gradually improve the industrial ecology, and explore and practice multi-dimensional medical and industrial collaborative innovation model.
Philips (China) Investment Co., Ltd.
Patients and medical care workers are the core of Philips' health care system. The services provided cross the boundaries of pure health care services and can provide users with a comprehensive and excellent health care service experience, which can greatly improve the patient's medical care effect and significantly reduce the Overall medical care costs. As a healthcare expert in heart disease, oncology, critical care and women, Philips is always committed to developing and providing healthcare solutions to provide users with value for money, ranging from disease prevention, radiation diagnosis to treatment, to Health management and monitoring, etc.
Philips (China) Investment Co., Ltd.
Patients and medical care workers are the core of Philips' health care system. The services provided cross the boundaries of pure health care services and can provide users with a comprehensive and excellent health care service experience, which can greatly improve the patient's medical care effect and significantly reduce the Overall medical care costs. As a healthcare expert in heart disease, oncology, critical care and women, Philips is always committed to developing and providing healthcare solutions to provide users with value for money, ranging from disease prevention, radiation diagnosis to treatment, to Health management and monitoring, etc.
Shenzhen Anke High-tech Co., Ltd.
Shenzhen Anke High-Tech Co., Ltd. was established in 1986 and is one of the leading large-scale medical imaging equipment providers in China. Anke specializes in the research, development, production, sales and technical services of large-scale medical imaging equipment and minimally invasive therapeutic equipment. Its main products include X-ray computer tomography system (CT), magnetic resonance imaging system (MRI), X-ray photography system ( XR), minimally invasive therapeutic equipment. Since its establishment, the company has the mission of developing national high-tech medical devices, committed to the research and development of key technologies in the field of large-scale medical imaging equipment and independent brand product innovation, and continues to promote the import substitution process of mid-to-high-end medical device products. Anke is one of the earliest domestic companies to independently develop large-scale medical imaging equipment and minimally invasive therapeutic equipment, and has deep technical accumulation. As a national high-tech enterprise and Guangdong Engineering Technology Research and Development Center, the company has undertaken national scientific research and industry with the goal of striving to achieve the industrialization, scale and efficiency of high-end medical imaging equipment in my country, and has undertaken the "Digital Diagnosis and Treatment Equipment R&D" project of the Ministry of Science and Technology and other national scientific research and industry with the goal of striving to achieve the industrialization, scale and efficiency of China's high-end medical imaging equipment. and actively participated in the drafting of a number of industry standards related to medical imaging equipment such as CT, vehicle-mounted CT, digital breast machines, etc., making positive contributions to promoting the development of the industry. Based on technology and product innovation, Anke has gradually built a multi-level three-dimensional marketing service network covering major provinces and cities across the country and facing medical institutions at all levels. Through various forms such as industry-university-research cooperation, window demonstration hospitals, etc. Cooperation, the company's products have been sold to 100 Grade A hospitals across the country and have been widely recognized. In addition, the company actively implements the "going overseas" strategy, focusing on the CIS, Latin America, Africa and other regions, and promoting the popularization of medical imaging equipment worldwide.
Shenzhen Anke High-tech Co., Ltd.
Shenzhen Anke High-Tech Co., Ltd. was established in 1986 and is one of the leading large-scale medical imaging equipment providers in China. Anke specializes in the research, development, production, sales and technical services of large-scale medical imaging equipment and minimally invasive therapeutic equipment. Its main products include X-ray computer tomography system (CT), magnetic resonance imaging system (MRI), X-ray photography system ( XR), minimally invasive therapeutic equipment. Since its establishment, the company has the mission of developing national high-tech medical devices, committed to the research and development of key technologies in the field of large-scale medical imaging equipment and independent brand product innovation, and continues to promote the import substitution process of mid-to-high-end medical device products. Anke is one of the earliest domestic companies to independently develop large-scale medical imaging equipment and minimally invasive therapeutic equipment, and has deep technical accumulation. As a national high-tech enterprise and Guangdong Engineering Technology Research and Development Center, the company has undertaken national scientific research and industry with the goal of striving to achieve the industrialization, scale and efficiency of high-end medical imaging equipment in my country, and has undertaken the "Digital Diagnosis and Treatment Equipment R&D" project of the Ministry of Science and Technology and other national scientific research and industry with the goal of striving to achieve the industrialization, scale and efficiency of China's high-end medical imaging equipment. and actively participated in the drafting of a number of industry standards related to medical imaging equipment such as CT, vehicle-mounted CT, digital breast machines, etc., making positive contributions to promoting the development of the industry. Based on technology and product innovation, Anke has gradually built a multi-level three-dimensional marketing service network covering major provinces and cities across the country and facing medical institutions at all levels. Through various forms such as industry-university-research cooperation, window demonstration hospitals, etc. Cooperation, the company's products have been sold to 100 Grade A hospitals across the country and have been widely recognized. In addition, the company actively implements the "going overseas" strategy, focusing on the CIS, Latin America, Africa and other regions, and promoting the popularization of medical imaging equipment worldwide.
SinoVision Technology (Beijing) Co., Ltd.
Sanovia Technology (Beijing) Co., Ltd. is headquartered in Beijing Economic and Technological Development Zone, China. It is composed of engineers and many elites in China's local medical equipment industry, and is dedicated to building a medical imaging equipment industry system integrating R&D, production and sales. SanoVisit will always adhere to the development concept of innovation-oriented and quality-oriented. On the one hand, it will maintain the advantages of imaging equipment research and development with CT technology as the core. At the same time, it will focus on the wide application of network functions and big data technology in the medical field and Development, focusing on intelligent and networked product research and development, insisting on adding in quality, application and service, and providing global medical institutions with integrated solutions that combine imaging equipment, cloud service platforms and remote diagnosis technology. Under the guidance of the Belt and Road policy, Sanovia has reached a cooperation intention with partners in some countries and regions along the route, and at the same time negotiated industrial cooperation matters with countries that have their own needs for improving and developing the medical industry. Sanovia is willing to work hand in hand with you to make greater contributions to the cause of human health.
SinoVision Technology (Beijing) Co., Ltd.
Sanovia Technology (Beijing) Co., Ltd. is headquartered in Beijing Economic and Technological Development Zone, China. It is composed of engineers and many elites in China's local medical equipment industry, and is dedicated to building a medical imaging equipment industry system integrating R&D, production and sales. SanoVisit will always adhere to the development concept of innovation-oriented and quality-oriented. On the one hand, it will maintain the advantages of imaging equipment research and development with CT technology as the core. At the same time, it will focus on the wide application of network functions and big data technology in the medical field and Development, focusing on intelligent and networked product research and development, insisting on adding in quality, application and service, and providing global medical institutions with integrated solutions that combine imaging equipment, cloud service platforms and remote diagnosis technology. Under the guidance of the Belt and Road policy, Sanovia has reached a cooperation intention with partners in some countries and regions along the route, and at the same time negotiated industrial cooperation matters with countries that have their own needs for improving and developing the medical industry. Sanovia is willing to work hand in hand with you to make greater contributions to the cause of human health.
Beijing Wandong Medical Technology Co., Ltd.
Wandong Medical began in 1955 and is committed to innovation in medical imaging technology and provides high-quality medical imaging products and services for clinical practice. Headquartered in Chaoyang Park, Zhongguancun Science and Technology Park, it has R&D and manufacturing bases in Beijing and Suzhou. The company's imaging products cover MRI, CT, DSA, DR, DRF, digital breast machines, mobile DR, and ultrasound diagnostic equipment, providing combined solutions to clinical practice to create value for customers. Wandong Medical plans to develop clinical and cutting-edge technology research and development, matrix, and tackle core technologies. It has 3 R&D production bases and 5 R&D centers, and its business covers more than 90 countries and regions.
Beijing Wandong Medical Technology Co., Ltd.
Wandong Medical began in 1955 and is committed to innovation in medical imaging technology and provides high-quality medical imaging products and services for clinical practice. Headquartered in Chaoyang Park, Zhongguancun Science and Technology Park, it has R&D and manufacturing bases in Beijing and Suzhou. The company's imaging products cover MRI, CT, DSA, DR, DRF, digital breast machines, mobile DR, and ultrasound diagnostic equipment, providing combined solutions to clinical practice to create value for customers. Wandong Medical plans to develop clinical and cutting-edge technology research and development, matrix, and tackle core technologies. It has 3 R&D production bases and 5 R&D centers, and its business covers more than 90 countries and regions.
Mingfeng Medical Systems Co., Ltd.
Mingfeng Medical Systems Co., Ltd. was established in 2011. It is a high-tech enterprise focusing on the research and development, production, sales and technical services of medical imaging equipment, and is committed to providing high-quality products and services to medical institutions around the world. After more than ten years of innovative research and development, Mingfeng Medical has developed into one of the companies with relatively complete CT product lines in the field of medical imaging in China, and is also one of the domestic medical device companies that can produce high-end CT and PET/CT. The company has always attached importance to independent technological innovation and product research and development, and has been deeply involved in the field of medical imaging equipment. It has scientific research institutions such as provincial key enterprise research institutes, Zhejiang Province CT and molecular imaging key laboratories, Zhejiang Province postdoctoral workstations, Zhejiang Foreign Expert workstations and other scientific research institutions. Relying on Zhejiang Province's leading innovation and entrepreneurship team, the company has gathered experts from the fields of materials science, nuclear physics, clinical medicine, information technology and mechanical engineering to build a collaborative and efficient R&D system, and overcome the technical barriers of multidisciplinary intersections. The company has accumulated a series of technologies in CT detector technology, SiPM-based PET detector technology, CT and PET/CT image reconstruction technology, intelligent workflow technology, intelligent point-to-point dynamic detector temperature control technology, detector noise suppression technology, etc. Results. With continuous R&D investment and deep product technology accumulation, the company's CT and PET/CT series products have reached the domestic leading and international advanced level in a number of performance indicators. As a project-consulting unit or participating unit, the company has participated in a number of major scientific research and application demonstration projects of the Ministry of Science and Technology, the National Development and Reform Commission, the Ministry of Industry and Information Technology and the National Health Commission. After more than ten years of continuous expansion of product lines and markets, the company has enriched its product lines from a single product to a wide range of product lines, from mid- and low-end products to high-end products, and from domestic market to international markets. The company adheres to the core concept of "innovation, focus, responsibility", and is determined to do a good job in technological research and development, steady and consolidate operation management, and pioneering and enterprising marketing and services. Mingfeng Medical will keep up with the cutting-edge technologies of the global medical imaging equipment market in the future and continue to overcome the situation. The technical problems of the botched neck are to further complete the product chain, and stand firm in the commanding heights of ultra-high-end products and technologies, and strive to develop into the backbone of the revitalization of national high-end medical imaging equipment, making greater contributions to the development of China's medical and healthcare industry.
Mingfeng Medical Systems Co., Ltd.
Mingfeng Medical Systems Co., Ltd. was established in 2011. It is a high-tech enterprise focusing on the research and development, production, sales and technical services of medical imaging equipment, and is committed to providing high-quality products and services to medical institutions around the world. After more than ten years of innovative research and development, Mingfeng Medical has developed into one of the companies with relatively complete CT product lines in the field of medical imaging in China, and is also one of the domestic medical device companies that can produce high-end CT and PET/CT. The company has always attached importance to independent technological innovation and product research and development, and has been deeply involved in the field of medical imaging equipment. It has scientific research institutions such as provincial key enterprise research institutes, Zhejiang Province CT and molecular imaging key laboratories, Zhejiang Province postdoctoral workstations, Zhejiang Foreign Expert workstations and other scientific research institutions. Relying on Zhejiang Province's leading innovation and entrepreneurship team, the company has gathered experts from the fields of materials science, nuclear physics, clinical medicine, information technology and mechanical engineering to build a collaborative and efficient R&D system, and overcome the technical barriers of multidisciplinary intersections. The company has accumulated a series of technologies in CT detector technology, SiPM-based PET detector technology, CT and PET/CT image reconstruction technology, intelligent workflow technology, intelligent point-to-point dynamic detector temperature control technology, detector noise suppression technology, etc. Results. With continuous R&D investment and deep product technology accumulation, the company's CT and PET/CT series products have reached the domestic leading and international advanced level in a number of performance indicators. As a project-consulting unit or participating unit, the company has participated in a number of major scientific research and application demonstration projects of the Ministry of Science and Technology, the National Development and Reform Commission, the Ministry of Industry and Information Technology and the National Health Commission. After more than ten years of continuous expansion of product lines and markets, the company has enriched its product lines from a single product to a wide range of product lines, from mid- and low-end products to high-end products, and from domestic market to international markets. The company adheres to the core concept of "innovation, focus, responsibility", and is determined to do a good job in technological research and development, steady and consolidate operation management, and pioneering and enterprising marketing and services. Mingfeng Medical will keep up with the cutting-edge technologies of the global medical imaging equipment market in the future and continue to overcome the situation. The technical problems of the botched neck are to further complete the product chain, and stand firm in the commanding heights of ultra-high-end products and technologies, and strive to develop into the backbone of the revitalization of national high-end medical imaging equipment, making greater contributions to the development of China's medical and healthcare industry.
Canon Medical Systems (China) Co., Ltd.
Since its inception, Canon Co., Ltd. (hereinafter referred to as "Canon") has always adhered to the corporate philosophy of "symbiosis", aiming to create world-class high-quality products as its goal, and develop towards diversification and globalization. At present, Canon's career is centered on optical technology, covering a wide range of fields such as imaging system products, office products and industrial equipment. The group headquarters in Tokyo is closely linked to regional headquarters in the Americas, Europe, Asia and Oceania, and has built a business system that organically combines globalization and localization. Canon successfully developed an X-ray indirect camera in 1940, marking Canon's official entry into the medical business. Since the start of its business, Canon Medical Systems Co., Ltd. (hereinafter referred to as "Canon Medical"), with the business slogan "Made for Life", has been committed to contributing to the medical and health of users around the world and carrying out global business; it has continuously launched Modern medical equipment is indispensable, high-quality and high-value-added medical equipment, serving users around the world. Now, Canon relies on its advantageous imaging technology to actively develop medical equipment such as digital X-ray photography and ophthalmology examinations. Canon Medical is committed to building a more secure and safe society, and continuously developing and expanding medical business. Canon Medical entered the rapidly growing Chinese market in 1975. Through the sales and after-sales service of medical equipment, as well as the joint efforts with Chinese companies and talents in R&D and production, its business has achieved steady and continuous growth. The Chinese market occupies an increasingly important position in Canon's global career and its development has attracted much attention. In the future development of Canon Medical Systems (China) Co., Ltd. will give full play to the advantages of its existing service system while strengthening cooperation with hospitals through joint research and other means. The global medical market is undergoing earth-shaking changes, and the Chinese market is no exception. Canon Medical will continue to reform and innovate Canon Medical's high-quality science and technology, continue to create new value for Chinese users, provide better services for the ever-changing Chinese medical market, and contribute to China's medical cause and people's health.
Canon Medical Systems (China) Co., Ltd.
Since its inception, Canon Co., Ltd. (hereinafter referred to as "Canon") has always adhered to the corporate philosophy of "symbiosis", aiming to create world-class high-quality products as its goal, and develop towards diversification and globalization. At present, Canon's career is centered on optical technology, covering a wide range of fields such as imaging system products, office products and industrial equipment. The group headquarters in Tokyo is closely linked to regional headquarters in the Americas, Europe, Asia and Oceania, and has built a business system that organically combines globalization and localization. Canon successfully developed an X-ray indirect camera in 1940, marking Canon's official entry into the medical business. Since the start of its business, Canon Medical Systems Co., Ltd. (hereinafter referred to as "Canon Medical"), with the business slogan "Made for Life", has been committed to contributing to the medical and health of users around the world and carrying out global business; it has continuously launched Modern medical equipment is indispensable, high-quality and high-value-added medical equipment, serving users around the world. Now, Canon relies on its advantageous imaging technology to actively develop medical equipment such as digital X-ray photography and ophthalmology examinations. Canon Medical is committed to building a more secure and safe society, and continuously developing and expanding medical business. Canon Medical entered the rapidly growing Chinese market in 1975. Through the sales and after-sales service of medical equipment, as well as the joint efforts with Chinese companies and talents in R&D and production, its business has achieved steady and continuous growth. The Chinese market occupies an increasingly important position in Canon's global career and its development has attracted much attention. In the future development of Canon Medical Systems (China) Co., Ltd. will give full play to the advantages of its existing service system while strengthening cooperation with hospitals through joint research and other means. The global medical market is undergoing earth-shaking changes, and the Chinese market is no exception. Canon Medical will continue to reform and innovate Canon Medical's high-quality science and technology, continue to create new value for Chinese users, provide better services for the ever-changing Chinese medical market, and contribute to China's medical cause and people's health.
Shanghai Electric Kangda Medical Instrument Group Co., Ltd.
Kangda InterContinental Medical Equipment Co., Ltd. is located in the Meishan Bonded Zone, Beilun, Ningbo, Binhai, and is committed to creating a "intelligent manufacturing" platform for the research and development of medical equipment. Kanda InterContinental takes revitalizing national enterprises and forging the "Healthy Chinese Dream" as its mission, and takes the courage to innovate, strive for excellence, and share win-win as its core concepts, providing medical institutions with medical equipment that benefits the health of the people and is suitable for the health needs of the Chinese people. The Kangda InterContinental (Meishan) Health Industrial Park, under construction, covers an area of about 319 mu and has a construction area of about 330,000 square meters. 2.5 billion yuan will be invested to build a new medical industrial park. The industrial park covers the research and development of medical products, intelligent production of medical imaging equipment, clinical training, specialized medical care, etc., thereby creating a medical industry chain integrating the teaching, research and development, production, training and services of medical products. The product chain includes a variety of medical equipment such as magnetic resonance imaging systems, CT, digital X-ray imaging equipment, color ultrasound, oral medical equipment, tumor diagnosis equipment, and other medical equipment. Gathering medical technology talents and strength, Kangda Intercontinental has invested a lot of money in the research and development of medical imaging products. Currently, the products that Kangda Intercontinental has obtained a registration certificate and put into production include Feitian 32 row 16-layer CT, Feitian 1.5T magnetic resonance, color ultrasound, and tablet small C and DR, etc. Feitian CT 32-row isometric detector, 75cm aperture rack, low-dose fast scanning, has been evaluated many times by experts and clinical trials: Kangda Intercontinental Feitian CT scan speed is fast and has excellent imaging, which is completely comparable to imported equipment. Feitian CT, color ultrasound, tablet C, etc. will make up for some industrial gaps in Zhejiang Province and are high-end medical equipment that the people can truly afford. Large-scale radio equipment under development includes 0.7T superconducting magnetic resonance, 1.5T superconducting magnetic resonance, 3.0T superconducting magnetic resonance, PET-magnetic resonance, 64 rows of 128 layer CT, 128 rows of cardiac imaging CT, PET-CT, etc. In the next one to two years, more products will obtain medical device registration certificates and conduct large-scale production at Kangda Intercontinental Meishan Health Industrial Park. Kangda InterContinental is actively laying out the implementation plan of intelligent manufacturing. After the production workshop is completed, it will build an intelligent production platform for medical equipment through intelligent manufacturing plans such as "smart factory", "smart production", and "smart warehousing", and at the same time, with the help of With the support of industrial capital, we will build a platform for medical equipment research and development and manufacturing to provide medical equipment suitable for needs for a healthy China. By cooperating with other medical equipment companies and establishing industry-university-research cooperation with higher education institutions and scientific research institutions, we can develop medical equipment that meets market demand on a higher and wider platform, and deliver medical equipment that meets the requirements to the "Belt and Road" The areas along the route will make efforts and contributions to improving the quality of China's national independent medical device brands and the development of the big health industry! Keep up with policy guidance and create an intelligent medical equipment manufacturing platform that complies with the "Made in China 2025" specifications and standards. And by building a clinical application and training center that integrates a series of functions such as teaching, clinical research, applied research, and clinical training, we will improve the clinical level and diagnostic level of grassroots medical personnel. Actively responding to the "Belt and Road" strategy, Kanda Intercontinental will contribute more Chinese medical device products to the world, export high-quality medical services and clinical training, and make its own contribution to the development of the big health industry. A brand new brand, Kanda Intercontinental, will rise slowly in Meishan, Ningbo.
Shanghai Electric Kangda Medical Instrument Group Co., Ltd.
Kangda InterContinental Medical Equipment Co., Ltd. is located in the Meishan Bonded Zone, Beilun, Ningbo, Binhai, and is committed to creating a "intelligent manufacturing" platform for the research and development of medical equipment. Kanda InterContinental takes revitalizing national enterprises and forging the "Healthy Chinese Dream" as its mission, and takes the courage to innovate, strive for excellence, and share win-win as its core concepts, providing medical institutions with medical equipment that benefits the health of the people and is suitable for the health needs of the Chinese people. The Kangda InterContinental (Meishan) Health Industrial Park, under construction, covers an area of about 319 mu and has a construction area of about 330,000 square meters. 2.5 billion yuan will be invested to build a new medical industrial park. The industrial park covers the research and development of medical products, intelligent production of medical imaging equipment, clinical training, specialized medical care, etc., thereby creating a medical industry chain integrating the teaching, research and development, production, training and services of medical products. The product chain includes a variety of medical equipment such as magnetic resonance imaging systems, CT, digital X-ray imaging equipment, color ultrasound, oral medical equipment, tumor diagnosis equipment, and other medical equipment. Gathering medical technology talents and strength, Kangda Intercontinental has invested a lot of money in the research and development of medical imaging products. Currently, the products that Kangda Intercontinental has obtained a registration certificate and put into production include Feitian 32 row 16-layer CT, Feitian 1.5T magnetic resonance, color ultrasound, and tablet small C and DR, etc. Feitian CT 32-row isometric detector, 75cm aperture rack, low-dose fast scanning, has been evaluated many times by experts and clinical trials: Kangda Intercontinental Feitian CT scan speed is fast and has excellent imaging, which is completely comparable to imported equipment. Feitian CT, color ultrasound, tablet C, etc. will make up for some industrial gaps in Zhejiang Province and are high-end medical equipment that the people can truly afford. Large-scale radio equipment under development includes 0.7T superconducting magnetic resonance, 1.5T superconducting magnetic resonance, 3.0T superconducting magnetic resonance, PET-magnetic resonance, 64 rows of 128 layer CT, 128 rows of cardiac imaging CT, PET-CT, etc. In the next one to two years, more products will obtain medical device registration certificates and conduct large-scale production at Kangda Intercontinental Meishan Health Industrial Park. Kangda InterContinental is actively laying out the implementation plan of intelligent manufacturing. After the production workshop is completed, it will build an intelligent production platform for medical equipment through intelligent manufacturing plans such as "smart factory", "smart production", and "smart warehousing", and at the same time, with the help of With the support of industrial capital, we will build a platform for medical equipment research and development and manufacturing to provide medical equipment suitable for needs for a healthy China. By cooperating with other medical equipment companies and establishing industry-university-research cooperation with higher education institutions and scientific research institutions, we can develop medical equipment that meets market demand on a higher and wider platform, and deliver medical equipment that meets the requirements to the "Belt and Road" The areas along the route will make efforts and contributions to improving the quality of China's national independent medical device brands and the development of the big health industry! Keep up with policy guidance and create an intelligent medical equipment manufacturing platform that complies with the "Made in China 2025" specifications and standards. And by building a clinical application and training center that integrates a series of functions such as teaching, clinical research, applied research, and clinical training, we will improve the clinical level and diagnostic level of grassroots medical personnel. Actively responding to the "Belt and Road" strategy, Kanda Intercontinental will contribute more Chinese medical device products to the world, export high-quality medical services and clinical training, and make its own contribution to the development of the big health industry. A brand new brand, Kanda Intercontinental, will rise slowly in Meishan, Ningbo.
Brook (Beijing) Technology Co., Ltd.
Brooke is committed to enabling scientists to make breakthrough discoveries and develop new applications to improve the quality of human life. Brooke’s high-performance scientific instrumentation and high-value analytical and diagnostic solutions enable scientists to explore life and materials at the molecular, cellular and micro levels. With close cooperation with customers, Brooke has achieved innovative breakthroughs and productivity improvements in life science molecular research, application and pharmaceutical applications, as well as microscopy, nanoanalysis and industrial applications, and has created many customer success stories. In recent years, Brooke has also become a provider of high-performance systems for cell biology, preclinical imaging, clinical imaging and proteomics research, clinical microbiology and molecular pathology research. Today, Brooke’s more than 7,500 employees worldwide are addressing this long-term challenge in more than 90 workplaces on various continents. Brooke insists on having a high reputation among customers for his extensive product and solutions and a broad foundation of installation systems. As one of the world's renowned analytical instrument companies, Brooke is committed to further fully meeting customer needs and continuously developing advanced technology and innovative solutions for today's analytical research work.
Brook (Beijing) Technology Co., Ltd.
Brooke is committed to enabling scientists to make breakthrough discoveries and develop new applications to improve the quality of human life. Brooke’s high-performance scientific instrumentation and high-value analytical and diagnostic solutions enable scientists to explore life and materials at the molecular, cellular and micro levels. With close cooperation with customers, Brooke has achieved innovative breakthroughs and productivity improvements in life science molecular research, application and pharmaceutical applications, as well as microscopy, nanoanalysis and industrial applications, and has created many customer success stories. In recent years, Brooke has also become a provider of high-performance systems for cell biology, preclinical imaging, clinical imaging and proteomics research, clinical microbiology and molecular pathology research. Today, Brooke’s more than 7,500 employees worldwide are addressing this long-term challenge in more than 90 workplaces on various continents. Brooke insists on having a high reputation among customers for his extensive product and solutions and a broad foundation of installation systems. As one of the world's renowned analytical instrument companies, Brooke is committed to further fully meeting customer needs and continuously developing advanced technology and innovative solutions for today's analytical research work.
Agfa HealthCare provides digital imaging solutions, including radiography, mammography, and healthcare IT systems, with a focus on improving patient care.
Agfa-Gevaert Group
Agfa HealthCare provides digital imaging solutions, including radiography, mammography, and healthcare IT systems, with a focus on improving patient care.
Planmed offers specialized imaging solutions, including 3D mammography and orthopedic imaging systems, known for their precision and advanced technology.
Planmeca Oy
Planmed offers specialized imaging solutions, including 3D mammography and orthopedic imaging systems, known for their precision and advanced technology.
Analogic provides advanced imaging solutions, including CT and ultrasound systems, with a focus on innovation and clinical excellence.
Analogic Corporation
Analogic provides advanced imaging solutions, including CT and ultrasound systems, with a focus on innovation and clinical excellence.
Shimadzu Medical offers a range of imaging equipment, including X-ray, fluoroscopy, and angiography systems, known for their precision and durability.
Shimadzu Corporation
Shimadzu Medical offers a range of imaging equipment, including X-ray, fluoroscopy, and angiography systems, known for their precision and durability.
Carestream Health provides digital imaging solutions, including X-ray systems, medical imaging software, and healthcare IT solutions.
Carestream Health, Inc.
Carestream Health provides digital imaging solutions, including X-ray systems, medical imaging software, and healthcare IT solutions.
Fujifilm Holdings Corporation
Known for its advanced imaging technologies, Fujifilm provides laparoscopic systems for minimally invasive surgery.
Fujifilm Holdings Corporation
Known for its advanced imaging technologies, Fujifilm provides laparoscopic systems for minimally invasive surgery.
Hologic is a global medical technology company focused on improving women's health through early detection and treatment.
Hologic, Inc.
Hologic is a global medical technology company focused on improving women's health through early detection and treatment.
Samsung Electronics Co., Ltd.
Samsung Healthcare provides CT imaging systems with a focus on delivering high-quality images and innovative solutions for diverse clinical needs.
Samsung Electronics Co., Ltd.
Samsung Healthcare provides CT imaging systems with a focus on delivering high-quality images and innovative solutions for diverse clinical needs.
Eizo Imaging Technology (Suzhou) Co., Ltd.
Yizhuo Imaging Technology (Suzhou) Co., Ltd. is the first wholly-owned subsidiary established by EIZO Corporation in China, with a total investment of US$22.5 million. The company's business areas cover the development, production, sales of commercial offices, medical imaging, operating room integration, creative work, professional color, air traffic control, security monitoring and other fields. EIZO Corporation (EIZO Co., Ltd.) EIZO (Tokyo Stock Exchange: 6737) means image in Japanese, EIZO Corporation is a vision technology company that develops and manufactures high-end display solutions. Yizhuo integrates hardware and software technology with consulting, hosting and other services to help customers in business, mapping, gaming, medicine, air traffic control, maritime and other fields work comfortably, efficiently and creatively. Headquartered in Shirayama, Japan, Yizhuo Company has R&D and production facilities in Japan, China, Germany and the United States, and has offices in more than 100 countries.
Eizo Imaging Technology (Suzhou) Co., Ltd.
Yizhuo Imaging Technology (Suzhou) Co., Ltd. is the first wholly-owned subsidiary established by EIZO Corporation in China, with a total investment of US$22.5 million. The company's business areas cover the development, production, sales of commercial offices, medical imaging, operating room integration, creative work, professional color, air traffic control, security monitoring and other fields. EIZO Corporation (EIZO Co., Ltd.) EIZO (Tokyo Stock Exchange: 6737) means image in Japanese, EIZO Corporation is a vision technology company that develops and manufactures high-end display solutions. Yizhuo integrates hardware and software technology with consulting, hosting and other services to help customers in business, mapping, gaming, medicine, air traffic control, maritime and other fields work comfortably, efficiently and creatively. Headquartered in Shirayama, Japan, Yizhuo Company has R&D and production facilities in Japan, China, Germany and the United States, and has offices in more than 100 countries.
